← Back to Search

Investigational MRI Technology Development (Avery HS Trial)

Phase 4
Recruiting
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
When contrast is being administered: healthy volunteers with a GFR≥60 ml/min
When contrast is being administered: patients with a GFR ≥30 ml/min
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights

Avery HS Trial Summary

This trial will test new sequences on patients and healthy volunteers.

Who is the study for?
This trial is for adults over 18 who can complete an MR safety questionnaire and consent in English. Participants must have a certain level of kidney function, with patients requiring a GFR ≥30 ml/min and healthy volunteers needing a GFR≥60 ml/min. It excludes prisoners, those with acute kidney issues or allergies to gadolinium contrast media, pregnant or breastfeeding women, and anyone unable to undergo MRI.Check my eligibility
What is being tested?
The study is testing new software and hardware sequences for MRI scans on both patients with Body Dysmorphic Disorder and healthy volunteers. Some participants will receive an injection of Gadavist contrast agent during their scan.See study design
What are the potential side effects?
Potential side effects may include reactions to the Gadavist contrast agent such as headache, nausea, dizziness, or local pain where injected. The MRI procedure itself is generally safe but may cause discomfort due to claustrophobia or lying still.

Avery HS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My kidney function is good, with a GFR of 60 ml/min or higher.
Select...
My kidney function is good enough for contrast dye (GFR ≥30).
Select...
I am 18 years old or older.

Avery HS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Conduct clinical protocol development and validation
Secondary outcome measures
Demonstrate and train

Avery HS Trial Design

4Treatment groups
Experimental Treatment
Group I: Volunteer w/ contrastExperimental Treatment2 Interventions
Volunteers undergo 1 research MRI for research purposes
Group II: Volunteer no contrastExperimental Treatment1 Intervention
Volunteers undergo 1 research MRI for research purposes
Group III: Patient w/ ContrastExperimental Treatment2 Interventions
Patients will add 15 minutes to their SOC MRI for research purposes
Group IV: Patient no contrastExperimental Treatment1 Intervention
Patients will add 15 minutes to their SOC MRI for research purposes
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MRI
2009
Completed Phase 2
~1370

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,589 Previous Clinical Trials
915,126 Total Patients Enrolled

Media Library

Volunteer w/ contrast Clinical Trial Eligibility Overview. Trial Name: NCT05215132 — Phase 4
Body Dysmorphic Disorder Clinical Trial 2023: Volunteer w/ contrast Highlights & Side Effects. Trial Name: NCT05215132 — Phase 4
Volunteer w/ contrast 2023 Treatment Timeline for Medical Study. Trial Name: NCT05215132 — Phase 4
Body Dysmorphic Disorder Research Study Groups: Volunteer w/ contrast, Volunteer no contrast, Patient w/ Contrast, Patient no contrast

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current enrollment rate for this clinical research?

"Affirmative. Data hosted on clinicaltrials.gov elucidates that this medical study, which was initially posted on December 19th 2019, is currently recruiting patients. Approximately 2000 participants must be enrolled from 2 distinct centres of care."

Answered by AI

Is there availability for patients to participate in this trial?

"This clinical trial, which originated on December 19th 2019 and was recently updated on July 21st 2022, is currently recruiting patients."

Answered by AI

Is this treatment option safe for those receiving it?

"Our risk assessment placed this intervention's safety at a 3 since it has already been passed-through Phase 4 and is officially sanctioned for medical use."

Answered by AI

Does the age requirement for this trial extend past 55 years?

"According to the study's admission criteria, those aged between 18 and 90 are qualified for this clinical trial. Additionally, there are specialized interventions available for individuals under 18 as well as over 65 years of age - 3 trials in total for minors and 8 for seniors."

Answered by AI

What criteria would make someone an ideal candidate to join this research trial?

"This clinical trial seeks 2000 individuals between the ages of 18 and 90, who possess image or body-related conditions. In addition to this age range requirement, participants must also have a glomerular filtration rate (GFR) ≥30 ml/min when contrast is administered; be able to comprehend and provide informed consent in English; and for healthy volunteers, their GFR should be ≥60 ml/min."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Investigational MRI Clinical Software and Hardware
Ryan Avery 2019. "Investigational MRI Clinical Software and Hardware". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05215132.
~295 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top